Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade
Open Access
- 3 July 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 13 (1), 327-8
- https://doi.org/10.1186/1471-2407-13-327
Abstract
Background Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of AMP-activated protein kinase (AMPK), a metabolic sensor, hampers cervical cancer cell growth through blocking the Wnt/β-catenin signaling activity. Here, we report that activated AMPK (p-AMPK) also inhibits cervical cancer cell growth by counteracting FOXM1 function. Methods Effect of the activation of AMPK on FOXM1 expression was examined by hypoxia and glucose deprivation, as well as pharmacological AMPK activators such as A23187, AICAR and metformin. RT Q-PCR and Western blot analysis were employed to investigate the activities of AMPK, FOXM1 and AKT/FOXO3a signaling. Results Consistent with our previous findings, the activation of AMPK by either AMPK activators such as AICAR, A23187, metformin, glucose deprivation or hypoxia significantly inhibited the cervical cancer cell growth. Importantly, we found that activated AMPK activity was concomitantly associated with the reduction of both the mRNA and protein levels of FOXM1. Mechanistically, we showed that activated AMPK was able to reduce AKT mediated phosphorylation of p-FOXO3a (Ser253). Interestingly, activated AMPK could not cause any significant changes in FOXM1 in cervical cancer cells in which endogenous FOXO3a levels were knocked down using siRNAs, suggesting that FOXO3a is involved in the suppression of FOXM1. Conclusion Taken together, our results suggest the activated AMPK impedes cervical cancer cell growth through reducing the expression of FOXM1.Keywords
This publication has 50 references indexed in Scilit:
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer CellsGastroenterology, 2012
- AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric CancerCancer Research, 2012
- The AMPK-FoxO3A axis as a target for cancer treatmentCell Cycle, 2010
- Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.Oncology Reports, 2008
- The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor α in Breast Cancer CellsPublished by Elsevier BV ,2006
- The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung CancerCancer Research, 2006
- AMP-activated protein kinase: balancing the scalesBiochimie, 2005
- FoxM1 is required for execution of the mitotic programme and chromosome stabilityNature, 2005
- Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressorGenes & Development, 2004
- Over‐expression of FoxM1 stimulates cyclin B1 expressionFEBS Letters, 2001